FDA Enforcement Class II Terminated

Proteus 235 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Recall: Z-2715-2020 · Reported August 5, 2020

Enforcement

Recall Number
Z-2715-2020
Event ID
86076
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ion Beam Applications S.A.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
August 5, 2020
Initiation Date
July 17, 2020
Classification Date
July 27, 2020
Termination Date
August 30, 2021
Address
Chemin Du Cyclotron 3, N/A, Louvain-la-neuve, N/A, N/A, Belgium

Description

Proteus 235 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Reason

IBA became aware of an issue to resume aborted irradiations because the plan to complete the treatment cannot be loaded.

Code Info

Serial Number: Manufacture date SAT.140 (US): manufactured May 2019 SBF.112 (EU): manufactured October 2019

Distribution

US: VA OUS: Belgium

Quantity

2 Units